A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects

Summary

Jiashen Tablets as an oral, compound traditional chinese medicine prepatations, have an effect on improvement of the heart failure. This study will assess the safety, tolerability and pharmacokinetics (PK) of Jiashen Tablets, following oral administration of single and multiple ascending dose of Jiashen Tablets.

Conditions

• Healthy

Interventions

DRUG

Jiashen Tablets

1 tablet

DRUG

Jiashen Tablets

2 tablets

DRUG

Jiashen Tablets

4 tablets

DRUG

Jiashen Tablets

6 tablets

DRUG

Jiashen Tablets

8 tablets

DRUG

Jiashen Tablets

9 tablets

DRUG

Jiashen Tablets Placebo

1 tablet

DRUG

Jiashen Tablets Placebo

2 tablets

DRUG

Jiashen Tablets Placebo

4 tablets

DRUG

Jiashen Tablets Placebo

6 tablets

DRUG

Jiashen Tablets Placebo

8 tablets

DRUG

Jiashen Tablets Placebo

9 tablets

Sponsors & Collaborators

• Tasly Pharmaceutical Group Co., Ltd

  lead INDUSTRY

Principal Investigators

• Rui Liu · Tasly Group, Co. Ltd.

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

50 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2020-06-29

Primary Completion

2021-04-09

Completion

2021-04-09

Countries

• China

Study Locations